Vanda Pharmaceuticals (VNDA) Retained Earnings (2010 - 2026)
Vanda Pharmaceuticals' (VNDA) quarterly Retained Earnings came in at $212000.0 in Q1 2026, down 44.65% year-on-year from $383000.0 in Q1 2025, and down 66.3% quarter-over-quarter from $629000.0 in Q4 2025.
Vanda Pharmaceuticals (VNDA) Retained Earnings (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals has disclosed Retained Earnings across 17 years of filings, most recently posting $212000.0 for Q1 2026.
- Retained Earnings for Q1 2026 came in at $212000.0, down 44.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $212000.0 (down 44.65% YoY), and the FY2025 annual result was $629000.0, up 750.0% from the prior year.
- Retained Earnings came in at $212000.0 for Q1 2026 at Vanda Pharmaceuticals, down from $629000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $702000.0 in Q3 2024 to a low of -$159.5 million in Q1 2024.
- The 5-year median for Retained Earnings is -$255000.0 (2023), against an average of -$18.6 million.
- Across the five-year window, Retained Earnings tumbled 62463.92% in 2024 and surged 750.0% in 2025, its largest moves.
- Vanda Pharmaceuticals' Retained Earnings stood at -$1.2 million in 2022, then jumped by 97.49% to -$30000.0 in 2023, then soared by 346.67% to $74000.0 in 2024, then soared by 750.0% to $629000.0 in 2025, then tumbled by 66.3% to $212000.0 in 2026.
- The last three Retained Earnings figures came in at $212000.0 (Q1 2026), $629000.0 (Q4 2025), and $540000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Vanda Pharmaceuticals | 345.46 Mn | 143.15 Mn | 48.56 Mn | 212,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212,000.00 |
| Dec 31, 2025 | 629,000.00 |
| Sep 30, 2025 | 540,000.00 |
| Jun 30, 2025 | 396,000.00 |
| Mar 31, 2025 | 383,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 702,000.00 |
| Jun 30, 2024 | -330,000.00 |
| Mar 31, 2024 | -159.54 Mn |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | -152.99 Mn |
| Jun 30, 2023 | -865,000.00 |
| Mar 31, 2023 | -255,000.00 |
| Dec 31, 2022 | -1.19 Mn |
| Sep 30, 2022 | -1.49 Mn |
| Jun 30, 2022 | -1.43 Mn |
| Mar 31, 2022 | -1.33 Mn |
| Dec 31, 2021 | -175,000.00 |
| Sep 30, 2021 | -171.25 Mn |
| Jun 30, 2021 | -179.03 Mn |